Monitoring_VBG DPD_NN activity_NN may_MD be_VB important_JJ in_IN the_DT management_NN of_IN patients_NNS experiencing_VBG severe_JJ toxicity_NN secondary_JJ to_TO FUra_NN chemotherapy_NN ._.
Regulation_NN of_IN the_DT BZLF1_NN promoter_NN of_IN Epstein-Barr_JJ virus_NN by_IN second_JJ messengers_NNS in_IN anti-immunoglobulin-treated_JJ B_NN cells_NNS ._.
IL-2_NN induced_VBD less_RBR STAT1_NN alpha_NN activation_NN and_CC IFN-alpha_NN induced_VBD greater_JJR STAT5_NN activation_NN in_IN NK3.3_NN cells_NNS compared_VBN with_IN preactivated_JJ primary_JJ NK_NN cells_NNS ._.
However_RB ,_, upon_IN transition_NN from_IN a_DT proliferating_JJ G1_NN to_TO a_DT resting_JJ state_NN of_IN the_DT cell_NN cycle_NN the_DT three_CD genes_NNS were_VBD differently_RB regulated_VBN ._.
We_PRP show_VBP that_IN the_DT inducible_JJ nuclear_JJ form_NN of_IN NF-AT_NN contains_VBZ Fos_NN and_CC Jun_NN proteins_NNS ._.
The_DT cyclin-dependent_JJ kinase_NN inhibitor_NN p27Kip1_NN plays_VBZ an_DT important_JJ role_NN in_IN regulating_VBG cell-cycle_JJ progression_NN ._.
The_DT effect_NN of_IN transmembrane_NN signaling_NN of_IN T_NN cells_NNS with_IN ionomycin_NN ,_, sn-1,2_NN dioctanoyl_NN glycerol_NN ,_, was_VBD also_RB determined_VBN ._.
Dimerization_NN among_IN transcription_NN factors_NNS has_VBZ become_VBN a_DT recurrent_JJ theme_NN in_IN the_DT regulation_NN of_IN eukaryotic_JJ gene_NN expression_NN ._.
To_TO evaluate_VB the_DT role_NN in_IN myelopoiesis_NN ,_, transgenic_JJ mice_NNS expressing_VBG were_VBD engineered_VBN ._.
IEF-1_NN ,_, a_DT pancreatic_JJ beta-cell_NN type-specific_JJ complex_NN believed_VBN to_TO regulate_VB insulin_NN expression_NN ,_, is_VBZ demonstrated_VBN to_TO consist_VB of_IN at_IN least_JJS two_CD distinct_JJ species_NNS ,_, one_CD of_IN which_WDT does_VBZ not_RB contain_VB Pan_NN molecules_NNS ._.
All_DT patients_NNS were_VBD characterized_VBN by_IN an_DT Addisonian_JJ picture_NN weakness_NN ,_, weight_NN loss_NN ,_, hypotension_NN ,_, hyponatremia_NN ,_, and_CC intense_JJ mucocutaneous_JJ melanosis_NN ._.
Recent_JJ studies_NNS have_VBP identified_VBN homologues_NNS of_IN STAT5_NN ,_, STAT5A_NN ,_, and_CC STAT5B_NN ,_, as_RB well_RB as_IN lower_JJR molecular_JJ weight_NN variants_NNS of_IN STAT5_NN ._.
Furthermore_RB ,_, we_PRP evaluated_VBD the_DT mineralocorticoid_NN receptor_NN MR_NN count_NN in_IN mononuclear_JJ leukocytes_NNS in_IN the_DT 2_CD groups_NNS ._.
Various_JJ cellular_JJ stimuli_NNS relieve_VBP this_DT inhibition_NN by_IN mechanisms_NNS largely_RB unknown_JJ ,_, leading_VBG to_TO NF-kappa_NN B_NN nuclear_JJ localization_NN and_CC transactivation_NN of_IN target_NN genes_NNS ._.
Western_NN blot_NN with_IN an_DT N-terminal_JJ antibody_NN showed_VBD normal_JJ levels_NNS of_IN immunoreactive_JJ GR_NN ,_, but_CC quantitative_JJ analysis_NN with_IN isoform-specific_JJ C-terminal_JJ antibodies_NNS revealed_VBD a_DT markedly_RB reduced_VBN GRalpha_NN expression_NN ,_, and_CC high_JJ GRbeta_NN expression_NN ._.
Induction_NN of_IN fra-1_NN following_VBG engagement_NN of_IN CD40_NN did_VBD not_RB require_VB protein_NN synthesis_NN ,_, suggesting_VBG that_IN the_DT PKC-dependent_JJ linkage_NN between_IN CD40_NN and_CC fra-1_NN is_VBZ direct_JJ ._.
NF-AT_NN is_VBZ thought_VBN to_TO consist_VB of_IN two_CD components_NNS :_: a_DT ubiquitous_JJ ,_, inducible_JJ nuclear_JJ component_NN that_WDT we_PRP have_VBP identified_VBN as_IN Fos_NN and_CC Jun_NN proteins_NNS ,_, and_CC a_DT preexisting_VBG ,_, T_NN cell-specific_JJ component_NN NF-ATp_NN which_WDT is_VBZ the_DT target_NN for_IN the_DT immunosuppressive_JJ agents_NNS cyclosporin_NN A_NN CsA_NN and_CC FK506_NN ._.
Little_JJ is_VBZ known_VBN of_IN expression_NN of_IN 1,25-LRB-OH-RRB-2D3_NN receptor_NN RNA_NN in_IN hematopoietic_JJ cells_NNS ._.
BCL-2-deficient_JJ T_NN cells_NNS demonstrate_VBP accelerated_VBN cell_NN cycle_NN progression_NN and_CC increased_VBN apoptosis_NN following_VBG activation_NN ._.
All_DT TCC_NN expressed_VBD equal_JJ levels_NNS of_IN the_DT low-affinity_JJ IL-12R_NN beta1_NN subunit_NN ._.
Glucocorticoid_NN receptor_NN characteristics_NNS in_IN monocytes_NNS of_IN patients_NNS with_IN corticosteroid-resistant_JJ bronchial_JJ asthma_NN ._.
Previous_JJ studies_NNS have_VBP demonstrated_VBN that_IN human_JJ HL-60_NN myeloid_JJ leukemia_NN cells_NNS differentiate_VBP in_IN response_NN to_TO phorbol_NN esters_NNS ._.
The_DT transcriptionally_RB active_JJ factors_NNS mediating_VBG the_DT effect_NN of_IN the_DT HTLV-I_NN Tax_NN transactivator_NN on_IN the_DT IL-2R_NN alpha_NN kappa_NN B_NN enhancer_NN include_VBP the_DT product_NN of_IN the_DT c-rel_NN proto-oncogene_NN ._.
The_DT transcription_NN factor_NN GATA-1_NN is_VBZ expressed_VBN in_IN a_DT subset_NN of_IN hemopoietic_JJ cells_NNS ,_, where_WRB it_PRP mediates_VBZ the_DT cell-type_JJ specific_JJ expression_NN of_IN several_JJ genes_NNS ._.
The_DT S._FW cerevisiae_FW and_CC Sch._FW pombe_FW systems_NNS support_VBP effects_NNS of_IN acidic_JJ activator_NN proteins_NNS ,_, provided_VBN a_DT further_JJ protein_NN fraction_NN from_IN S._FW cerevisiae_FW is_VBZ supplied_VBN ._.
